LIDOCAINE SULFATE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C14H22N2O.H2O4S
Molecular Weight	332.416
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OS(O)(=O)=O.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C

InChI

InChIKey=WKECJNYGULLKBJ-UHFFFAOYSA-N

InChI=1S/C14H22N2O.H2O4S/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;1-5(2,3)4/h7-9H,5-6,10H2,1-4H3,(H,15,17);(H2,1,2,3,4)

HIDE SMILES / InChI

Molecular Formula	C14H22N2O
Molecular Weight	234.3373
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	H2O4S
Molecular Weight	98.078
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 16:00:51 UTC 2023` Edited by `admin` on `Sat Dec 16 16:00:51 UTC 2023`
Record UNII	EYR84TH492
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LIDOCAINE SULFATE

Common Name

English

2',6'-ACETOXYLIDIDE, 2-(DIETHYLAMINO)-, SULFATE (1:1)

Systematic Name

English

ACETAMIDE, 2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)-, SULFATE (1:1)

Systematic Name

English

Lidocaine sulfate [WHO-DD]

Common Name

English

Code System Code Type Description

FDA UNII

EYR84TH492

Created by admin on Sat Dec 16 16:00:51 UTC 2023 , Edited by admin on Sat Dec 16 16:00:51 UTC 2023

PRIMARY

CAS

24847-67-4

Created by admin on Sat Dec 16 16:00:51 UTC 2023 , Edited by admin on Sat Dec 16 16:00:51 UTC 2023

PRIMARY

PUBCHEM

46912271

Created by admin on Sat Dec 16 16:00:51 UTC 2023 , Edited by admin on Sat Dec 16 16:00:51 UTC 2023

PRIMARY

Related Record Type Details


					98PI200987

LIDOCAINE

PARENT -> SALT/SOLVATE

Amount:

Related Record Type Details


					98PI200987

LIDOCAINE

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Volume of Distribution	PHARMACOKINETIC				Crosses blood-brain barrier